Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

Santiago Grau,1 Jose Ramon Azanza,2 Isabel Ruiz,3 Carlos Vallejo,4 Josep Mensa,5 Johan Maertens,6 Werner J Heinz,7 Jon Andoni Barrueta,8 Carmen Peral,9 Francisco Jesús Mesa,8 Miguel Barrado,10 Claudie Charbonneau,11 Darío Rubio-Rodríguez,12 Carlos Rubio-Terr&eacu...

Full description

Bibliographic Details
Main Authors: Grau S, Azanza JR, Ruiz I, Vallejo C, Mensa J, Maertens J, Heinz WJ, Barrueta JA, Peral C, Mesa FJ, Barrado M, Charbonneau C, Rubio-Rodríguez D, Rubio-Terrés C
Format: Article
Language:English
Published: Dove Medical Press 2016-12-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Anidulafungin
cost-effectiveness
galactomannan
invasive aspergillosis
voriconazole
Online Access:https://www.dovepress.com/cost-effectiveness-analysis-of-combination-antifungal-therapy-with-vor-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/cost-effectiveness-analysis-of-combination-antifungal-therapy-with-vor-peer-reviewed-article-CEOR

Similar Items